Search research articles
Contact Us
Filters
Showing results (241-250 of 283) with videos related to
Page
of 29
Sort By:
Journal of Crohn'S & Colitis
|
March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease
Florian Rieder, Giovanni Latella, Fernando Magro, et al.
Research Square
|
April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision Making
Reid Herran, Samuel Wilcox, Gal Hodish, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
David T Rubin, Iris Dotan, Aaron DuVall, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 1, 2016
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice
Hiroko Nagao-Kitamoto, Andrew B Shreiner, Merritt G Gillilland, et al.
Gastrointestinal Endoscopy
|
December 21, 2014
The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement
Neel S Choksi, Evan L Fogel, Gregory A Cote, et al.
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine
Kayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.
The Lancet. Gastroenterology & Hepatology
|
September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
Séverine Vermeire, Silvio Danese, Wen Zhou, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease
Shrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 283) with videos related to
Sort By:
Page
of 29
Journal of Crohn'S & Colitis
|
March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease
Florian Rieder, Giovanni Latella, Fernando Magro, et al.
Research Square
|
April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision Making
Reid Herran, Samuel Wilcox, Gal Hodish, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
David T Rubin, Iris Dotan, Aaron DuVall, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
November 1, 2016
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice
Hiroko Nagao-Kitamoto, Andrew B Shreiner, Merritt G Gillilland, et al.
Gastrointestinal Endoscopy
|
December 21, 2014
The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement
Neel S Choksi, Evan L Fogel, Gregory A Cote, et al.
The American Journal of Gastroenterology
|
June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch
Edward L Barnes, Laura Raffals, Taha Qazi, et al.
Gut
|
February 18, 2017
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 12, 2020
Coronavirus Disease 2019 (COVID-19) Clinical Trial Oversight at a Major Academic Medical Center: Approach of Michigan Medicine
Kayte Spector-Bagdady, Peter D R Higgins, Keith D Aaronson, et al.
The Lancet. Gastroenterology & Hepatology
|
September 8, 2023
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
Séverine Vermeire, Silvio Danese, Wen Zhou, et al.
Journal of Crohn'S & Colitis
|
February 5, 2019
CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor α in Active Crohn's Disease
Shrinivas Bishu, Mohammed El Zaatari, Atsushi Hayashi, et al.
Page
of 29